Organovo Holdings For Profit

Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
Technology: Organ Engineering
Industry: Regenerative medicine
Headquarters: United States
Investors Number: 2
Total Funding: $117.4M
Estimated Revenue: $10M to $50M
Last Funding Type: Series E

Visit Website
info@organovo.com
twitter.com/Organovo/
Register and Claim Ownership